Luis Felipe Flores-Suárez Selected Research

Luis Felipe Flores-Suárez Research Topics

Disease

11	Vasculitis (Vasculitides) 05/2024 - 04/2004
7	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 02/2024 - 04/2015
5	Granulomatosis with Polyangiitis (Wegener's Granulomatosis) 09/2020 - 04/2004
4	Hemorrhage 02/2024 - 01/2020
3	Infections 09/2020 - 04/2004
3	Interstitial Lung Diseases (Interstitial Lung Disease) 09/2017 - 01/2017
2	Asthma (Bronchial Asthma) 10/2020 - 06/2020
2	Pathologic Constriction (Stenosis) 10/2020 - 05/2008
2	Microscopic Polyangiitis 09/2020 - 11/2017
2	Systemic Vasculitis 09/2020 - 03/2017
2	Glomerulonephritis 06/2020 - 03/2017
2	Scleritis (Episcleritis) 01/2016 - 12/2015
1	Inflammation (Inflammations) 10/2020
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 09/2020
1	Ulcerative Colitis 09/2020
1	Connective Tissue Diseases (Connective Tissue Disease) 09/2020
1	Crohn Disease (Crohn's Disease) 09/2020
1	Endocarditis 09/2020
1	Liver Diseases (Liver Disease) 09/2020
1	Neoplasms (Cancer) 09/2020
1	Nephritis 09/2020
1	Autoimmune Hepatitis 09/2020
1	Anti-Glomerular Basement Membrane Disease (Goodpasture's Syndrome) 09/2020
1	Idiopathic Interstitial Pneumonias 09/2020
1	Churg-Strauss Syndrome (Allergic Angiitis) 06/2020
1	Kidney Diseases (Kidney Disease) 06/2020
1	Polyneuropathies (Polyneuropathy) 06/2020
1	Skin Manifestations 06/2020
1	Purpura 06/2020
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 07/2017
1	Lung Diseases (Lung Disease) 07/2017
1	Vocal Cord Paralysis 03/2017
1	Chronic Renal Insufficiency 01/2017
1	Thyroid Diseases (Thyroid Disease) 01/2017
1	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 01/2017
1	Fistula 06/2016
1	Respiratory Tract Diseases (Respiratory Tract Disease) 03/2015
1	Blindness (Hysterical Blindness) 01/2012
1	Amaurosis Fugax 01/2012
1	Pulmonary Tuberculosis 01/2010
1	Tuberculosis (Tuberculoses) 01/2010
1	Human Influenza (Influenza) 09/2009
1	Vascular Skin Diseases 10/2006
1	Lupus Nephritis 01/2006
1	Dermatomyositis (Dermatopolymyositis) 02/2002
1	Amyopathic dermatomyositis 02/2002
1	Hypertriglyceridemia 02/2002

Drug/Important Bio-Agent (IBA)

15	Antineutrophil Cytoplasmic Antibodies (ANCA)IBA 02/2024 - 05/2008
4	GlucocorticoidsIBA 05/2024 - 12/2015
4	Rituximab (Mabthera)FDA Link 09/2017 - 12/2015
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 08/2023 - 04/2004
3	Peroxidase (Myeloperoxidase)IBA 09/2020 - 03/2017
3	AntigensIBA 09/2020 - 01/2010
3	AutoantibodiesIBA 09/2020 - 01/2010
2	AntibodiesIBA 09/2020 - 06/2020
2	Biomarkers (Surrogate Marker)IBA 11/2017 - 11/2012
2	Cocaine (Cocaine HCl)IBA 06/2016 - 01/2015
2	Immunosuppressive Agents (Immunosuppressants)IBA 12/2015 - 01/2006
2	SteroidsIBA 01/2006 - 02/2002
1	Antifibrotic AgentsIBA 10/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2012
1	bactericidal permeability increasing proteinIBA 01/2010
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 10/2006
1	Mycophenolic Acid (Cellcept)FDA LinkGeneric 01/2006
1	SolutionsIBA 04/2004
1	Thomsen-Friedenreich antibodiesIBA 04/2004
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 04/2004
1	Dapsone FDA Link 02/2002
1	Fibric Acids (Fibrates)IBA 02/2002
1	Methotrexate (Mexate)FDA LinkGeneric 02/2002
1	Antimalarials (Antimalarial Agents)IBA 02/2002

Therapy/Procedure

6	Therapeutics 01/2016 - 02/2002
5	Plasma Exchange 05/2024 - 09/2017
1	Artificial Respiration (Mechanical Ventilation) 05/2024
1	Lipectomy (Liposuction) 01/2017
1	General Anesthesia 01/2017
1	Remission Induction 12/2015
1	Aftercare (After-Treatment) 01/2010
1	Transplantation 01/2006